ResearchMoz

Cancer Symptoms Partnering 2007-2013

Current Partnering
Published Date » 2013-10-08
No. Of Pages » 150
 The Cancer Symptoms Partnering 2007-2013 report provides understanding and access to the cancer symptoms partnering deals and agreements entered into by the worlds leading healthcare companies. 
   
 
 
 Trends in solid tumor cancer partnering deals 
 Top solid tumor cancer deals by value 
 Deals listed by company A-Z, industry sector, stage of development, technology type 
 
 
   
 The Solid Tumor Cancer Partnering 2007-2013 provides understanding and access to the solid tumor cancer partnering deals and agreements entered into by the worlds leading healthcare companies. 
   
  This report provides details of thelatest cancer symptoms agreements announced in the healthcare sectors, covering:  
   
 
 
 Symptoms 
 Oral mucositis 
 Cancer pain...
TABLE OF CONTENT

Executive Summary
 
Chapter 1 – Introduction
 
Chapter 2 – Trends in cancer symptoms partnering
2.1. Introduction
2.2. Cancer symptoms partnering over the years
2.3. Bigpharma cancer symptoms dealmaking activity
2.4. Cancer symptoms partnering by deal type
2.5. Cancer symptoms partnering industry sector
2.6. Cancer symptoms partnering by stage of development
2.7. Cancer symptoms partnering by technology type
2.8. Disclosed financial deal terms for cancer symptoms partnering
2.8.1 Cancer symptoms headline values
2.8.2 Cancer symptoms upfront payments
2.8.3 Cancer symptoms milestone payments
2.8.4 Cancer symptoms royalty rates
 
Chapter 3 – Leading cancer symptoms deals
3.1. Introduction
3.2. Top cancer symptoms deals by value
3.3. Top cancer symptoms deals involving bigpharma
 
Chapter 4 – Dealmaking directory
4.1. Introduction
4.2. Company A-Z
4.3. By deal type
Asset purchase
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Contract service
Co-promotion
CRADA
Cross-licensing
Development
Distribution
Equity purchase
Evaluation
Grant
Joint venture
Licensing
Manufacturing
Marketing
Option
Promotion
Research
Settlement
Spin out
Sub-license
Supply
Termination
4.4. By industry sector
Academic
Bigpharma
Biotech
Drug delivery
Medical device
Diagnostic
Generic pharma
Government
Non-profit
Pharmaceutical
Research tools
Services
Specialty pharma
4.5. By stage of development
Discovery
Pre-clinical
Phase I
Phase II
Phase III
Registration
Marketed
4.6. By technology type
Analysis
Animal models
Assays
Bioinformatics
Biological compounds
Biomarkers
Biomaterials
Cell culture
Cell therapy
Clinical testing
Diagnostic - companion
Devices
Diagnostics
Discovery tools
DNA probes
Drug delivery
Enabling technology
Epigenetics
Equipment
Facilities
Gene therapy
Genomics
Imaging
Industrial chemicals
In vitro models
Monoclonal antibodies
Nanotechnology
Oligonucleotide
Peptides
Personalised medicine
Processes
Proteomics
Radio/Chemo-therapy
Recombinant DNA
Research services
Research supplies
RNA therapeutics
Screening
Small molecules
Stem cells
Vaccines
 
Chapter 5 – Partnering resource center
5.1. Online partnering
5.2. Partnering events
5.3. Further reading on dealmaking
 
Appendices
 
Appendix 1 – Deal type definitions
 
About Wildwood Ventures
Current Partnering
Current Agreements
Recent titles from CurrentPartnering
Order Form – Reports

List of Tables

NA

List of Figures

 
Figure 1: Cancer symptoms partnering since 2007
Figure 2: Bigpharma – top 50 – Cancer symptoms deals 2007 to 2013
Figure 3: Bigpharma cancer symptoms deal frequency – 2007 to 2013
Figure 4: Cancer symptoms partnering by deal type since 2007
Figure 5: Cancer symptoms partnering by industry sector since 2007
Figure 6: Cancer symptoms partnering by stage of development since 2007
Figure 7: Cancer symptoms partnering by technology type since 2007
Figure 8: Cancer symptoms deals with a headline value
Figure 9: Cancer symptoms deals with upfront payment values
Figure 10: Cancer symptoms deals with milestone payments
Figure 11: Cancer symptoms deals with royalty rates, %
Figure 12: Top cancer symptoms deals by value since 2007
Figure 13: Top cancer symptoms deals signed by bigpharma value since 2007
Figure 14: Online partnering resources
Figure 15: Forthcoming partnering events
Figure 16: Deal type definitions

Upcoming Reports:

Greece: market of fresh, chilled and frozen pig meat
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the fresh, chilled and frozen pig meat market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the fresh, chilled and frozen pig meat market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the...
Polyhydroxyalkanoate Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth And Forecast, 2013 - 2019
By - Transparency Market Research
Polyhydroxyalkanoate (PHA) is biodegradable linear polyesters produced naturally by the chemical reaction of bacterial fermentation on lipids or sugar. PHAs can be combined with a wide array of monomers which results in the formation of different types of materials exhibiting a variety of properties. PHAs are used in several applications including packaging of food & beverages and cosmetics, bio-medical applications and agricultural films among others.  Rising demand for biodegradable materials owing to the rising awareness among consumers regarding environment protection...
Protein Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Proteins are essential for good health; people affected by genetic disorders cannot produce these proteins. Examples of such proteins include insulin, various blood clotting factors, growth hormones and others. Protein therapy ensures efficient administration of these proteins to patients suffering from deficiency, resulting in effective therapeutic benefits. It is a type of medical treatment that possesses therapeutic effects in many diseases such as diabetes, brain diseases and cancer. Protein therapeutics are classified functionally into five major groups-  Group I:...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Healthcare Industry is China is Likely to Boost Green GDP Growth
May 26, 2015  
Leading business analysts are vying on the healthcare industry in China to emerge as the engine of the alleged green GDP growth. Green GDP growth entails environmentally sustainable economic growth. China has been increasingly adopting strategies to ascertain green development of its economic sectors. Healthcare industry of the country shouldn’t be left far behind as well. Speaking about...
E-Learning Course to Facilitate Communication in the Healthcare Industry Launched
May 26, 2015  
We are living in a time when communication is getting highly digitized. Digital technology is evolving at a rapid pace, and now it has expanded its realms to the healthcare industry as well. Recently, Wolters Kluwer from Consortium of Accredited Healthcare Organizations (CAHO) in collaboration with the Baptist Hospital in Bangalore, India released a new e-learning course on communication in...
Healthcare and Pharmaceutical Registers Higher Percent of Inventions than Tech Globally
May 26, 2015  
Thomson Reuters’ analysis on global patents indicates that the life science industry is on the cusp of taking over the tech sector with regards to propelling global innovation.  With a significant increase in the number of patents applied for and granted in 2014, than in any other year of history, experts suggest that humans have never been more proactively inventing....
French Government Forced Supermarkets to Give Unsold Food to Charity
May 26, 2015  
The national assembly of France has vowed a campaign on the wastage of food in the nation by passing a law to stop supermarkets from obliterating unsold food. In spite of destroying food, the super market chains are now enforced to give away the old food to charities or find a way to use these foods somewhere else. The deputy chief of the Socialist Party said that it was shocking to...
Officials from UC Davis and Zhuhai Signed MoU to establish the World Food Center in China
May 26, 2015  
The World Food Center in China is set to be the central office for the co-ordination of R&D and training activities in the field of food safety for many of the Joint Research Centers of China and United States spread across the nation. A unit for the center is being developed in a recently created economic zone in Guangdong province of Zhuhai, a region famous for its economic vitality,...